Greg Duncan is the Chief Executive Officer and Chairman of Dogwood Therapeutics, a clinical-stage biopharmaceutical company. Based in Alpharetta, GA.
Greg Duncan is the Chief Executive Officer and Chairman of Dogwood Therapeutics, a clinical-stage biopharmaceutical company, a position he has held since April 2020. He also serves as the Chairman and CEO of Virios Therapeutics, focusing on antiviral therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library